ACT — AlzChem AG Income Statement
0.000.00%
Last trade - 00:00
- €475.23m
- €527.77m
- €540.65m
- 88
- 58
- 63
- 83
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 376 | 379 | 422 | 542 | 541 |
Cost of Revenue | |||||
Gross Profit | 228 | 242 | 259 | 272 | 308 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 345 | 349 | 385 | 506 | 485 |
Operating Profit | 30.6 | 30.7 | 37.6 | 35.9 | 55.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 25.5 | 27.2 | 36.5 | 41.3 | 48.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 18.1 | 19.9 | 27.8 | 30.2 | 34.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 18 | 19.7 | 27.6 | 30.1 | 34.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 18 | 19.7 | 27.6 | 30.1 | 34.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.77 | 1.94 | 2.72 | 2.96 | 3.4 |
Dividends per Share |